Protein & Antibodies



Proteins, especially (monoclonal) antibodies, play an increasingly important role in today's pharmaceutical arena. A crucial aspect is to deliver the proteins at the desired site structurally intact and at therapeutic effective levels. Local or site-specific delivery is often a prerequisite to achieve optimal therapeutic benefit.

SynBiosys® is InnoCore’s platform to deliver proteins in a controlled manner for weeks up to over 6 months while maintaining the structural integrity and activity. Proteins are typically formulated using buffered aqueous solutions. However, protein solutions may be unstable and not suitable for further processing into advanced dosage forms. InnoCore uses stable dry powder forms of therapeutic proteins through lyophilization and spray-drying of proteins in amorphous sugar matrices.


The top ten benefits of our sustained release technologies for proteins:


Read more about our polymer platform SynBiosys® here